Fauji Foundation Hospital, Rawalpindi
Rawalpindi, Punjab Province, 44000, Pakistan
NCT Number: NCT07069192
This study evaluates the effect of passive smoke exposure on childhood asthma and the role of structured counseling in reducing SHS exposure and improving asthma control.
Looking for future studies?
Notify Me4 year–11 year
All sexes
Interventional
Not applicable
Rawalpindi, Punjab Province, 44000, Pakistan
A quasi-experimental study conducted at Fauji Foundation Hospital using a pre-post test design. The intervention group received structured caregiver counseling about the dangers of passive smoking and asthma management. The study used ACT scores to assess improvement in asthma control.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Received structured caregiver counseling - weekly sessions for 1 month and biweekly for the next 2 months.
Time frame: 3 months
Change in ACT Score from baseline to 3 months after intervention. ACT score of 19 is considered as normal Asthma control, less then 19 is considered as poor Asthma control and more than 19 ACT score is considered as good Asthma control
Foundation University Islamabad
Other
The Effect of Passive Smoke Exposure and Counselling Intervention in Childhood Asthma
Acronym: Asthma
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04617015
Asthma, Behavior
Buffalo, New York, United States
View Trial DetailsNCT04942379
Asthma, Behavior
Worcester, Massachusetts, United States
View Trial DetailsNCT02702687
Asthma, Bronchial Diseases
The Bronx, New York, United States
View Trial DetailsNCT03278561
Asthma, Bronchial Diseases
Rotterdam, South Holland, Netherlands
View Trial Details